Bavarian NordicDK0015998017BAVABAVA
Financials
Market Cap
$1.71B5Y beta
1.76EPS (TTM)
$2.808Free Float
77.98MP/E ratio (TTM)
7.81Revenue (TTM)
$1.02BEBITDA (TTM)
$386.35MFree Cashflow (TTM)
$20.46MPricing
Analyst Ratings
The price target is $38.86 and the stock is covered by 7 analysts.
Buy
6
Hold
1
Sell
0
Information
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in manufacturing of pharmaceutical preparations. The Company is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The Company deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The Company operates worldwide.